Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Johnson & Johnson COVID-19 vaccine being investigated for possible blood clot risk

The European Medicines Agency is investigating the issue with help from the FDA. At this stage, the group emphasized that it remains unclear if the Johnson & Johnson vaccine is associated with any specific blood clot risk.

AstraZeneca COVID-19 vaccine associated with risk of rare, potentially fatal blood clots

These blood clots have been responsible for a total of 18 deaths. Experts have continued to emphasize that the benefits of vaccination still outweigh the risks.

Patients with pulmonary arterial hypertension benefit from sotatercept treatment

After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance.

vaccine syringe covid-19 coronavirus

The blood clot plot continues: Countries suspend use of AstraZeneca COVID-19 vaccine in younger adults

The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults. 

Championing Alternative PAD Access in the Office-based Lab

Sponsored by Terumo

Improving access is at the center of a pair of new trends in treating peripheral artery disease (PAD). First is the office-based lab (OBL) expanding access to more PAD patients needing therapy, and the second is physicians more often choosing alternative access such as radial, tibial or pedal to treat those patients. Why now?

Thumbnail

NOACs associated with a 16% lower risk of bone fractures than warfarin

These findings are especially important, the authors explained, because the number of elderly patients on OACs continues to rise. 

AstraZeneca COVID-19 vaccine to get a blood clot warning in Canada

Officials confirmed, however, that they still believe the vaccine is safe and effective.  

Thumbnail

Mobile stroke units improve patient outcomes, reduce risk of disability

Researchers tracked data from more than 1,000 patients who received care from 2014 to 2020. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.